Thursday, July 9, 2026

biotech · PTHS

Pelthos Therapeutics

Pelthos Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

DURHAM, NC, USA HQ
Public company Type
PTHS · NYSE Ticker
Company details
Status
Public
HQ
DURHAM, NC, USA
Programs
0
Drugs
0
Patents
0
Intelligence · Drug Pipeline

Pelthos Therapeutics pipeline

Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Pelthos Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

No drugs indexed yet

We have not linked approved or pipeline drugs to this company profile yet.

View clinical projects →